Immix Biopharma Inc (NASDAQ: IMMX) shares are trading lower Monday after the company filed a new shelf registration statement ...

The biopharmaceutical sector finally regained its footing in 2025. Here are five issues that could determine whether the ...

ArriVent BioPharma's furmonertinib demonstrates robust efficacy, CNS penetration, and tolerability in early trials. Read why ...

Biopharma is reshaping the healthcare industry, and smart investors are paying close attention. The healthcare sector could see major changes as artificial intelligence accelerates drug discovery, ...